- Published at
- by manilatimes.net
positive
positive
News for Lytix Biopharma AS (LYTIX.OL)
- Published at
- by gurufocus.com
mixedmixedVerrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or the ”Company”) ( VRCA), a dermatology therapeutics co- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
mixedmixedVerrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
WEST CHESTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or ”the Company”) ( VRCA), a dermatology therapeutics co- Published at
- by gurufocus.com
positivepositiveVerrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
WEST CHESTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or ”the Company”) ( VRCA), a dermatology therapeutics com- Published at
- by benzinga.com
mixedmixedVerrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Verrica Pharmaceuticals (NASDAQ:VRCA)
WEST CHESTER, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
mixedmixedVerrica Announces Proposed Public Offering
WEST CHESTER, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (”Verrica” or the ”Company”) ( VRCA), a dermatology therapeutics com- Published at
- by manilatimes.net
mixedmixed- Published at
- by investing.com
mixedmixedVerrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York By Investing.com
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York- Published at
- by globenewswire.com
mixedmixedVerrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics...- Published at
- by globenewswire.com
positivepositiveVerrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the T
Global pivotal Phase 3 clinical trial would be conducted jointly by Verrica and Torii Pharmaceutical; trial expected to begin in the 1st half of 2025 ...- Published at
- by globenewswire.com
mixedmixedVerrica Pharmaceuticals Reports First Quarter 2024 Financial Results
– Reports YCANTH® revenue of $3.2M for first quarter of 2024 – – Over 228 million lives now covered to date on commercial insurance, managed Medicaid,...- Published at
- by globenewswire.com
mixedmixedVerrica Pharmaceuticals to Present at Upcoming Investor Conferences
WEST CHESTER, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics...- Published at
- by marketscreener.com
mixedmixedVerrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
– Reports YCANTH™ revenue of $1.9M for fourth quarter and $4.7M for full year 2023 – – Over 200 million lives now covered on commercial insurance and managed Medicaid plans – –...- Published at
- by globenewswire.com
mixedmixedVerrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
– Reports YCANTH™ revenue of $1.9M for fourth quarter and $4.7M for full year 2023 – – Over 200 million lives now covered on commercial insurance and...